CVE-2023-22868
Last modified
CVE-2023-22868 is a medium-severity vulnerability rated 5.4/10 on the CVSS scale. IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. EPSS estimates a 0.40% chance of exploitation in the next 30 days.
Description
IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.
Metrics
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions | Update |
|---|---|---|---|
| Ibm | Aspera Faspex | <= 4.4.1 | — |
| Ibm | Aspera Faspex | 4.4.1 | Patch Level 1 |
References
- https://exchange.xforce.ibmcloud.com/vulnerabilities/244117VDB Entry, Vendor Advisory
- https://www.ibm.com/support/pages/node/6952319Patch, Vendor Advisory
- https://exchange.xforce.ibmcloud.com/vulnerabilities/244117VDB Entry, Vendor Advisory
- https://www.ibm.com/support/pages/node/6952319Patch, Vendor Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-22868?
How severe is CVE-2023-22868?
How do I fix CVE-2023-22868?
Are you affected by CVE-2023-22868?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
